Cargando…

Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis

BACKGROUND: A large number of studies have provided a variety of heart failure management program (HF-MP) intervention modes. It is generally believed that HF-MP is effective, but the question of which type of program works best, what level of support is needed for an intervention to be effective, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Yongjie, Li, Zongren, Zhong, Qin, Rao, Chongyou, Hua, Yun, Wu, Rilige, Dong, Jing, Li, Da, Wang, Wenjun, He, Kunlun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972626/
https://www.ncbi.nlm.nih.gov/pubmed/36855208
http://dx.doi.org/10.1186/s13643-023-02183-8
_version_ 1784898361586876416
author Duan, Yongjie
Li, Zongren
Zhong, Qin
Rao, Chongyou
Hua, Yun
Wu, Rilige
Dong, Jing
Li, Da
Wang, Wenjun
He, Kunlun
author_facet Duan, Yongjie
Li, Zongren
Zhong, Qin
Rao, Chongyou
Hua, Yun
Wu, Rilige
Dong, Jing
Li, Da
Wang, Wenjun
He, Kunlun
author_sort Duan, Yongjie
collection PubMed
description BACKGROUND: A large number of studies have provided a variety of heart failure management program (HF-MP) intervention modes. It is generally believed that HF-MP is effective, but the question of which type of program works best, what level of support is needed for an intervention to be effective, and whether different subgroups of patients are best served by different types of programs is still confusing. METHODS: This study will search for published and unpublished randomized clinical trials in English examining HF-MP interventions in comparison with usual care. MEDLINE, Medlin In-Process and Non-Indexed, CENTRAL, CINAHL, EMBASE, and PsycINFO will be the databases. We will calibrate our eligibility criteria among the team. Each literature will be screened by at least two reviewers. Conflicts will be resolved through team discussion. A similar process will be used for data abstraction and quality appraisal. The results will be synthesized descriptively, and a network meta-analysis will be conducted if the studies are deemed methodologically, clinically, and statistically acceptable (e.g., I(2) < 50%). Moreover, potential moderators of efficacy will be analyzed using a meta-regression. DISCUSSION: This study will reduce the clinical heterogeneity and statistical heterogeneity of review and meta-analysis through a more scientific classification method to determine the most effective HF-MP in different subgroups of heart failure patients with different human resource investments and different intervention methods, providing high-quality evidence and guidance for clinical practice. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42021258521 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13643-023-02183-8.
format Online
Article
Text
id pubmed-9972626
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99726262023-03-01 Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis Duan, Yongjie Li, Zongren Zhong, Qin Rao, Chongyou Hua, Yun Wu, Rilige Dong, Jing Li, Da Wang, Wenjun He, Kunlun Syst Rev Protocol BACKGROUND: A large number of studies have provided a variety of heart failure management program (HF-MP) intervention modes. It is generally believed that HF-MP is effective, but the question of which type of program works best, what level of support is needed for an intervention to be effective, and whether different subgroups of patients are best served by different types of programs is still confusing. METHODS: This study will search for published and unpublished randomized clinical trials in English examining HF-MP interventions in comparison with usual care. MEDLINE, Medlin In-Process and Non-Indexed, CENTRAL, CINAHL, EMBASE, and PsycINFO will be the databases. We will calibrate our eligibility criteria among the team. Each literature will be screened by at least two reviewers. Conflicts will be resolved through team discussion. A similar process will be used for data abstraction and quality appraisal. The results will be synthesized descriptively, and a network meta-analysis will be conducted if the studies are deemed methodologically, clinically, and statistically acceptable (e.g., I(2) < 50%). Moreover, potential moderators of efficacy will be analyzed using a meta-regression. DISCUSSION: This study will reduce the clinical heterogeneity and statistical heterogeneity of review and meta-analysis through a more scientific classification method to determine the most effective HF-MP in different subgroups of heart failure patients with different human resource investments and different intervention methods, providing high-quality evidence and guidance for clinical practice. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42021258521 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13643-023-02183-8. BioMed Central 2023-02-28 /pmc/articles/PMC9972626/ /pubmed/36855208 http://dx.doi.org/10.1186/s13643-023-02183-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Protocol
Duan, Yongjie
Li, Zongren
Zhong, Qin
Rao, Chongyou
Hua, Yun
Wu, Rilige
Dong, Jing
Li, Da
Wang, Wenjun
He, Kunlun
Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis
title Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis
title_full Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis
title_fullStr Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis
title_full_unstemmed Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis
title_short Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis
title_sort efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972626/
https://www.ncbi.nlm.nih.gov/pubmed/36855208
http://dx.doi.org/10.1186/s13643-023-02183-8
work_keys_str_mv AT duanyongjie efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis
AT lizongren efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis
AT zhongqin efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis
AT raochongyou efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis
AT huayun efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis
AT wurilige efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis
AT dongjing efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis
AT lida efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis
AT wangwenjun efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis
AT hekunlun efficacyofdiseasemanagementprogramusedamongpatientswithchronicheartfailureprotocolforasystematicreviewandnetworkmetaanalysis